Thymocartin (acetate)

Thymocartin (TP 4) acetate is the 32-35 fragment of thymic factor (thymopoietin) . Thymocartin acetate inhibits apoptosis of peripheral blood lymphocytes in HIV infected individuals. Thymocartin acetate is potential for immunodeficiency diseases research[1][2].

Product Specifications

CAS Number

[85503-03-3]

Product Name Alternative

Thymopoietin II (32-35) (acetate) ; TP 4 (acetate)

UNSPSC

12352211

Target

Apoptosis

Type

Reference compound

Related Pathways

Apoptosis

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/thymocartin-acetate.html

Smiles

CC(O)=O.CC(C)[C@@H](C(O)=O)NC([C@H](CC(O)=O)NC([C@H](CCCCN)NC([C@@H](N)CCCNC(N)=N)=O)=O)=O

Molecular Formula

C23H44N8O9

Molecular Weight

576.64

References & Citations

[1]Lang S, et al. Transport and metabolic pathway of thymocartin (TP4) in excised bovine nasal mucosa. J Pharm Pharmacol. 1996 Nov;48 (11) :1190-6. |[2]la Szende B, et al., Reduction of apoptosis of in vitro cultured peripheral blood lymphocytes of HIV positive individuals by thymocartin[J]. Medical Science Monitor, 1997, 3 (4) : BR456-BR459.